DENA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
08/13/2026
Back to search
Official data from USPTO
JUMRYRA
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Case type
Application and registration
Recorded events
33
Latest update
08/13/2026
Trademark type
Word
Nice classes
5
Filing date
09/09/2022
Registration date
10/03/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/22/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
404
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
COGAN, BRITTNEY LORRAINE
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
33 publications found
DETH
DEATH OF INTERNATIONAL REGISTRATION
08/13/2026
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
01/30/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/09/2024
FIMP
FINAL DISPOSITION PROCESSED
01/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/18/2023
PUBO
PUBLISHED FOR OPPOSITION
07/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/28/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2023
ALIE
ASSIGNED TO LIE
06/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/17/2023
RFNT
REFUSAL PROCESSED BY IB
02/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/19/2023
RFRR
REFUSAL PROCESSED BY MPU
01/19/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/07/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/07/2022
CNRT
NON-FINAL ACTION WRITTEN
11/07/2022
DOCK
ASSIGNED TO EXAMINER
11/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/20/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/06/2022
Continuous trademark protection
Get notified about every new filing that threatens JUMRYRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.